Manulife Financial Corp.: A Deeply Discounted Way to Play the Fed Rate Hike

At a valuation of .90x book value, Manulife Financial Corp.’s (TSX:MFC)(NYSE:MFC) deep discount to its peers and strong dividend yield presents an excellent buy in the face of changing macroeconomic conditions.

| More on:
The Motley Fool

Fed rate hike jitters have once again gripped the capital markets following the surprisingly hawkish tone adopted by Chairwoman Janet Yellen and Vice Chair Stanley Fischer during last week’s Jackson Hole symposium. Moreover, in the days since Jackson Hole, the capital markets have begun to price in a one-in-three chance of a September hike (up from June’s near-zero levels), while the U.S. dollar has rallied sharply against its international counterparts.

For the commodity-heavy TSX, tighter U.S. monetary policy means lower commodity prices and, of course, an increase in the cost of debt borne by some of Canada’s most leveraged producers. Conversely, Canadian financials are expected to fare much better in the changing global macroeconomic conditions with higher U.S. interest rates expected to increase debt yields and the margins received on lending.

One such name in the financial sector that stands to benefit from a rate hike is Manulife Financial Corp. (TSX:MFC)(NYSE:MFC).

Manulife’s discounted valuation

Manulife’s most recent Q2 2016 core EPS came in at .40 (down 8% year over year), well below consensus estimates of .46. Moreover, adverse U.S. policy holder experience, predominantly from the long-term care sector, led to an 11% year-over-year decrease in U.S. core earnings, which, combined with management’s forecast of a pending $500 million actuarial charge in Q3 2016, compounded to a less than stellar report.

Unsurprisingly, Manulife was sold off by the market and currently trades well below its all-time highs made in June 2015. This noticeable drop in share value has contracted Manulife’s valuation to levels not seen since 2009 with a price-to-book value of just 0.90 times–below the sector median of 1.3 times among the Canadian Lifecos.

Discount not pricing in growth prospects

Manulife’s Asian division continue to be the company’s shining star. Sector core earnings were US$266 million in Q2 2016 compared to US$230 million in Q2 2015–an increase of 16%.

Furthermore, Manulife enjoyed a record quarter for annualized premium sales in Asia at US$627 million–34% higher than in Q2 2015, while its partnership with DBS continue to pay off as all four Asian segments recorded strong sales growth from the prior quarter. Wealth and Asset Management divisions across Canada and the U.S. also continued to perform strongly with a 7% year-over-year increase and 5% year-over-year increase, respectively.

Strong yield adds to bull case

Manulife stands to benefits from higher interest rates and subsequently a higher U.S. dollar as net income from foreign operations are translated into Canadian dollars. Furthermore, according to a recent research report by Barclays Capital, Manulife exhibits a roughly $100 million parallel movement on its earnings from a +/- 50 basis point change in interest rates (Q4 2015 figures), making the company an ideal way to seek exposure to potential a rate hike.

Finally, for income-oriented investors, Manulife pays out a hefty 4.04% yield, which has been steadily increasing over the last three years, even in the face of low energy prices and interest rates.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Zaw Tun has no position in any stocks mentioned.

More on Investing

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

Emerging Canadian AI Companies With Big Potential

These tech stocks are paving the way to an AI-filled future, but still offer enough growth ahead for a strong…

Read more »

Young Boy with Jet Pack Dreams of Flying
Tech Stocks

Is Constellation Software Stock a Buy, Sell, or Hold for 2025?

CSU stock has long been a strong option for high growth, high value stocks. But are there now too many…

Read more »

rising arrow with flames
Investing

2 Riskier Stocks With High Potential for Canadian Investors in November

Risky stocks such as Well Health Technologies have the potential to provide life-changing long-term returns.

Read more »

hand stacks coins
Dividend Stocks

3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold for a Decade

These three high-yield dividend stocks still have some work to do, but each are in steady areas that are only…

Read more »

senior man and woman stretch their legs on yoga mats outside
Dividend Stocks

TFSA: 2 Canadian Stocks to Buy and Hold Forever

Here are 2 TFSA-worthy Canadian stocks. Which one is a good buy for your TFSA today?

Read more »

Canada day banner background design of flag
Investing

Got $500? 5 Top Canadian Stocks to Buy and Hold

These top Canadian stocks have solid fundamentals with potential to outperform the benchmark index by a wide margin.

Read more »

man touches brain to show a good idea
Energy Stocks

1 No-Brainer Energy Stock to Buy With $500 Right Now

Should you buy a cyclical energy stock at its decade-high? Probably not. But read this before you make a decision.

Read more »

Asset Management
Stocks for Beginners

TFSA: 4 Canadian Stocks to Buy and Hold Forever

Thinking about what to buy with the new TFSA contribution space in 2025? These four Canadian stocks are worth holding…

Read more »